Perceptions of microbiome engineering technologies among hospital nurses

Healthcare acquired infections (HAIs) contribute substantially to the burden of morbidity and mortality among hospitalized patients in the United States and are a significant economic burden on the healthcare system. Approximately 3-5% of patients in the United States contract a HAI during the course of their treatment, and an estimated $7-14 billion are spent annually on treating these infections. HAIs also contribute to development of antimicrobial resistance (AMR), placing additional burden on the healthcare system and substantially raising the costs of treatment. Novel microbiome engineering technologies that address the HAI problem are currently being developed by researchers. We will conduct a qualitative study to assess the factors influencing the adoption of novel microbiome engineering among hospital nurses in the United States.